Drug Company

Jan 27, 2015 at 22:22 | Source: CNBC-TV18
Ranbaxy has lost out on its last big drug opportunity in the US market. The US drug regulator has denied the company 180-day exclusivity for the generic version of heart burn drug Nexium. However Archana Shukla reports that Ranbaxy's loss means good times for global rival Teva and Cipla.
Jan 23, 2015 at 11:14 | Source:
Beryl Drugs has entered into an agreement with the Managing Director, Madhya Pradesh Public Health Services, Procurement Corporation Ltd. (MPPHSCL), Bhopal (M.P.) for supply of the medicines manufactured by the Company to the tune of Rs 11.80 crore, which will boost up the Company's turnover by 60% to 65%.
Jan 22, 2015 at 13:34 | Source:
Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 07, 2015, to consider, approve and take on record the unaudited financial results for the quarter ended December 31, 2014.
Jan 20, 2015 at 14:06 | Source:
Beryl Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 20, 2015, has considered and approved the appointment of Mrs. Neha Sharma as Compliance Officer of the Company.
Jan 20, 2015 at 12:27 | Source: PTI
The company said it has been granted one product patent from Australia, two product patents from Japan and one product patent from Hong Kong corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases.
Jan 19, 2015 at 11:44 | Source:
Aarti Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 30, 2015, to consider, approve and take on record audited financial results and accounts for the quarter and nine month ended on December 31, 2014 and consider declaration of 2nd Interim dividend, if any.
Jan 13, 2015 at 19:29 | Source: PTI
In addition to the investment of USD 40 million in new equipment and technologies, the company will also augment related infrastructure, the release added.
Jan 12, 2015 at 12:53 | Source: CNBC-TV18
A third of Lupins 72 products are market leaders. The company remains positive on its business outlook.
Jan 07, 2015 at 09:59 | Source:
"Aurobindo received final approval from the US Food & Drug Administration to manufacture and market Valsartan tablets USP, 40mg, 80mg, 160mg and 320mg. The product is ready for launch," said the pharmaceutical company in its filing to the exchange.
Jan 06, 2015 at 18:47 | Source: PTI
The companies have received final approval from the US Food and Drug Administration (USFDA) for their abbreviated new drug applications for Valsartan tablets USP in multiple strengths of 40 mg, 80 mg, 160 mg and 320 mg, domestic firms said in separate statements.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

News across the web »
Jan 24, 2015 at 02:30 | Source: FirstPost
Jan 21, 2015 at 05:42 | Source: BBC